A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
Petzinger
G M
GM
Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.
Bressman
S B
SB
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology*; D009460:Neurologic Examination / Q000187:drug effects; D013747:Tetrabenazine / Q000008:administration & dosage / Q000009:adverse effects*; D013888:Thiothixene / Q000008:administration & dosage / Q000009:adverse effects*
D018726:Anti-Dyskinesia Agents; D013888:Thiothixene; D013747:Tetrabenazine